Navigation Links
Actual use of asthma medications contradicts guidelines
Date:3/28/2008

A study has found only 16% of the 352,082 Australians who filled a prescription for asthma preventer medications for the first time during the period July 2004 to June 2005, went on to use them regularly.

Most (61%) first time users did not fill another prescription in the next two years while 22% did so sporadically.

The research will be presented at the Thoracic Society of Australia and New Zealand (TSANZ) Conference which starts this Sunday in Melbourne.

The study was conducted by the Australian Centre for Asthma Monitoring, a collaborating unit of the Australian Institute of Health and Welfare based at the Woolcock Institute of Medical Research in Sydney. It analysed the anonymous Pharmaceutical Benefits Scheme (PBS) records of individuals who filled a prescription for preventer medications for asthma for the first time between July 2004 and June 2005, and their subsequent prescription activity over a period of two years. The most commonly used form of preventer medication is inhaled corticosteroids.

Professor Guy Marks, Head of Epidemiology Research at the Woolcock Institute, said the results indicated that the prevalence of one-time and sporadic use was highest in young adults (age 15-34 years) with regular use most common in adults aged 65 years and over.

The PBS dataset is a valuable tool for assessing patterns of asthma medication use, he said.

Importantly this study shows that while guidelines recommend regular use of preventer medication, this certainly isnt happening in the community. At least some of those people who are now using preventer medication sporadically, could be expected to benefit from regular use of this class of medications.


'/>"/>

Contact: Lucy Williams
lucyw@woolcock.org.au
61-403-753-028
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Dr. Oz and Dr. Roizen Prove That Aging Is Actually Reversible in You: Staying Young on Discovery Health
2. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
3. FDA Probing Possible Link Between Asthma Drug and Suicide Risk
4. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
5. Asthma medicines often not prescribed as national guidelines recommend
6. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
7. NIH Asthma Guidelines Will Leave Sufferers Breathing Easier This Spring
8. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
9. Aspirin Reduces Asthma Risk Among Older Women
10. UniCare of West Virginia Providing Assistance for Asthma Education Training
11. Treatment for mild asthma leads to improved lung function
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients 2
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 1Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 3Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 1Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 2Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 1Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 4